These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 382866
21. Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation. Keller R, Keist R, Van der Meide PH, Groscurth P, Aguet M, Leist TP. J Immunol; 1987 Apr 01; 138(7):2366-71. PubMed ID: 3104463 [Abstract] [Full Text] [Related]
22. Defective tumoricidal capacity of macrophages from A/J mice. II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice. Boraschi D, Meltzer MS. J Immunol; 1979 Apr 01; 122(4):1592-97. PubMed ID: 376721 [No Abstract] [Full Text] [Related]
24. Macrophage activation to kill Leishmania tropica: characterization of a T cell-derived factor that suppresses lymphokine-induced intracellular destruction of amastigotes. Nacy CA. J Immunol; 1984 Jul 01; 133(1):448-53. PubMed ID: 6202789 [Abstract] [Full Text] [Related]
25. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro]. Reisser D, Jeannin JF, Martin F. C R Seances Acad Sci III; 1982 Nov 08; 295(8):485-8. PubMed ID: 6819063 [Abstract] [Full Text] [Related]
32. Imbalanced accumulation of ribosomal RNA in macrophages activated in vivo or in vitro to a cytolytic stage. Varesio L. J Immunol; 1985 Feb 08; 134(2):1262-7. PubMed ID: 3965571 [Abstract] [Full Text] [Related]
33. Macrophages in resistance to rickettsial infections: characterization of lymphokines that induce rickettsiacidal activity in macrophages. Nacy CA, Leonard EJ, Meltzer MS. J Immunol; 1981 Jan 08; 126(1):204-7. PubMed ID: 7005333 [Abstract] [Full Text] [Related]
34. Prevention of tumor metastasis after surgical removal of primary tumor by using in vitro activated macrophages. Okuno K, Hashimoto T, Qian JH, Tsuchida T, Fujiwara H, Hamaoka T. Jpn J Clin Oncol; 1985 Mar 08; 15(1):87-94. PubMed ID: 3981817 [Abstract] [Full Text] [Related]
35. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens. James SL, Lazdins JK, Hieny S, Natovitz P. J Immunol; 1983 Sep 08; 131(3):1481-6. PubMed ID: 6350456 [Abstract] [Full Text] [Related]
36. Tumoricidal effector mechanisms of murine Bacillus Calmette-Guérin-activated macrophages: mediation of cytolysis, mitochondrial respiration inhibition, and release of intracellular iron by distinct mechanisms. Klostergaard J, Leroux ME, Ezell SM, Kull FC. Cancer Res; 1987 Apr 15; 47(8):2014-9. PubMed ID: 3828989 [Abstract] [Full Text] [Related]
37. Tumoricidal effector mechanisms of murine BCG-activated macrophages. I. Parameters of production and initial characterization of a cytolytic factor serologically related to necrosin. Klostergaard J, Foster WA, Leroux ME. J Biol Response Mod; 1987 Jun 15; 6(3):313-30. PubMed ID: 3298554 [Abstract] [Full Text] [Related]
38. Macrophage activation to kill Leishmania tropica: characterization of P/J mouse macrophage defects for lymphokine-induced antimicrobial activities against Leishmania tropica amastigotes. Nacy CA, Meltzer MS, Fortier AH. J Immunol; 1984 Dec 15; 133(6):3344-50. PubMed ID: 6491291 [Abstract] [Full Text] [Related]
40. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents. Germain RN, Williams RM, Benacerraf B. J Natl Cancer Inst; 1975 Mar 15; 54(3):709-20. PubMed ID: 1091741 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]